CoChat

A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® l-Theanine on Stress in a Healthy Adult Population

Open access
Evans, Malkanthi, McDonald, Alison C., Xiong, Lora, Crowley, David C., Guthrie, Najla · 2021 · Neurology and Therapy

The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.

Abstract

Stress is a complex life occurrence essential for survival and goal achievement but can be damaging in excess. Because of the high prevalence of stress in North America, a safe supplement that effectively reduces stress is in demand. The objective of this study was to investigate the efficacy and safety of AlphaWave® l-Theanine on whole-scalp and frontal alpha power, midline theta power, and salivary cortisol in healthy, moderately stressed adults. This was a randomized, triple-blind, placebo-controlled, crossover study that consisted of two study periods with a 7-day washout. A single dose of AlphaWave® l-Theanine (200 mg) or placebo was administered. To induce stress, a mental arithmetic test (MAT) was administered before and after the dose. Electroencephalogram, salivary cortisol, blood pressure, heart rate, self-reported stress, adverse events, clinical chemistry, and hematology were assessed to evaluate efficacy and safety. Increases in heart rate, blood pressure, and self-reported stress and state anxiety indicated that participants experienced stress during the MAT. AlphaWave® l-Theanine led to a greater increase in frontal region and whole-scalp alpha power 3 h post-dose compared to placebo (p ≤ 0.050). Within groups, there were increases in alpha power, at 3 h with AlphaWave® l-Theanine, over the whole recording and during the eyes-open portions (p ≤ 0.048) of the alpha task. The changes in alpha wave activity are supported by greater decreases in salivary cortisol 1 h post-dose (p < 0.001) with AlphaWave® l-Theanine compared to placebo. This study was conducted during the SARS-CoV-2 pandemic, which has had a rapid and significant effect on both physical and mental health around the world. A single dose of AlphaWave® l-Theanine significantly increased frontal region alpha power compared to placebo in response to an acute stress challenge. These changes are indicative of relaxation in the brain and suggest a calming response. AlphaWave® l-Theanine was found to be safe and well tolerated by participants. ClinicalTrials.gov identifier NCT04706494. Stress is a complex part of life that is essential for survival and achieving goals. Too much stress, however, can be damaging. There is a high prevalence of stress in North America, creating a demand for a safe and effective supplement to reduce it. This study investigated the effectiveness and safety of AlphaWave® l-Theanine on brainwaves and salivary cortisol in healthy, moderately stressed adults facing an acute stressor. This was a randomized, triple-blind, placebo-controlled, crossover study that consisted of two study periods with a 7-day washout. A single dose of 200 mg of AlphaWave® l-Theanine or placebo was administered before and after a mental arithmetic test to elicit acute stress. Electroencephalogram, salivary cortisol, blood pressure, heart rate, self-reported stress, and safety were assessed to evaluate efficacy and safety. This study was conducted during the coronavirus pandemic, which has had a rapid and significant effect on both physical and mental health around the world. A single dose of AlphaWave® l-Theanine had significant positive effects on brainwaves, salivary cortisol, and self-reported state anxiety compared to the placebo in response to an acute stress challenge. These changes are indicative of relaxation in the brain and suggest a calming response in a moderately stressed but otherwise healthy population. AlphaWave® l-Theanine was found to be safe and well tolerated by participants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40120-021-00284-x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Participant disposition. Of the 36 volunteers who were screened, 16 eligible participants were enrolled and randomized to receive AlphaWave® l-Theanine—placebo (n = 8) or placebo—AlphaWave® l-Theanine (n = 8)
Fig. 1 Participant disposition. Of the 36 volunteers who were screened, 16 eligible participants were enrolled and randomized to receive AlphaWave® l-Theanine—placebo (n = 8) or placebo—AlphaWave® l-Theanine (n = 8)CC BY-NC · PubMed Central
Fig. 2 Mean frontal alpha power for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of mean (SEM); a indicates different from pre-dose within-group p < 0.05, # indicates between-group p < 0.05, α indicates a within-group trend of p < 0.1
Fig. 2 Mean frontal alpha power for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of mean (SEM); a indicates different from pre-dose within-group p < 0.05, # indicates between-group p < 0.05, α indicates a within-group trend of p < 0.1CC BY-NC · PubMed Central
Fig. 3 Mean whole-scalp alpha power AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates different from pre-dose within-group p < 0.05, # indicates between-group p < 0.05, α indicates a trend of p < 0.1 within-group
Fig. 3 Mean whole-scalp alpha power AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates different from pre-dose within-group p < 0.05, # indicates between-group p < 0.05, α indicates a trend of p < 0.1 within-groupCC BY-NC · PubMed Central
Fig. 4 Mean heart rate for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates p < 0.05 within AlphaWave® l-Theanine compared to 0 min, b indicates p < 0.05 within placebo compared to 0 min, # indicates the change from 0 min between-group p < 0.05
Fig. 4 Mean heart rate for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates p < 0.05 within AlphaWave® l-Theanine compared to 0 min, b indicates p < 0.05 within placebo compared to 0 min, # indicates the change from 0 min between-group p < 0.05CC BY-NC · PubMed Central
Fig. 5 Mean systolic (solid) and diastolic (dashed) blood pressure for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates p < 0.05 within AlphaWave® l-Theanine compared to 0 min, b indicates p < 0.05 within placebo compared to 0 min, # indicates the change from 0 min between-group p < 0.05
Fig. 5 Mean systolic (solid) and diastolic (dashed) blood pressure for AlphaWave® l-Theanine and placebo at pre-dose, 1 h post-dose, and 3 h post-dose in the study population. Values presented are mean ± standard error of the mean (SEM); a indicates p < 0.05 within AlphaWave® l-Theanine compared to 0 min, b indicates p < 0.05 within placebo compared to 0 min, # indicates the change from 0 min between-group p < 0.05CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. Spielberger CD, et al. Development of the Spanish edition of the State-Trait Anxiety Inventory. Rev Interam Psicol. 1971;5(34):145–58.

Cited by

See all 25

Metadata

Authors
Evans, M., McDonald, A. C., Xiong, L., Crowley, D. C., & Guthrie, N.
Corresponding author
Evans, Malkanthi
Venue
Neurology and Therapy
Published
2021-09-25
Volume
10
Issue
2
Pages
1061-1078
ISSN
  • 2193-6536 (ISSN-L)
  • 2193-8253
OpenAlex
W3198981862
Cited by
25
References
41
Citations by year
2026: 7 · 2025: 9 · 2024: 5 · 2023: 2 · 2022: 2
FWCI
2.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurology and Therapy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Ethical Naturals Inc.
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
Keywords
theanine, acute stress, alpha activity, frontal alpha power, salivary cortisol, state anxiety, relaxation, supplement safety, heart rate, blood pressure, self-reported stress, healthy adults, placebo-controlled crossover trial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® l-Theanine on Stress in a Healthy Adult Population. https://app.cochat.ai/papers/10.1007/s40120-021-00284-x
The paper
Evans, M., McDonald, A. C., Xiong, L., Crowley, D. C., & Guthrie, N. (2021). A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave® l-Theanine on Stress in a Healthy Adult Population. Neurology and Therapy. https://doi.org/10.1007/s40120-021-00284-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.